Ancora Advisors’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,650
| Closed | -$865 | – | 1836 |
|
|
2023
Q2 | $865 | Hold |
7,650
| – | – | ﹤0.01% | 1545 |
|
|
2023
Q1 | $1.26K | Hold |
7,650
| – | – | ﹤0.01% | 1562 |
|
|
2022
Q4 | $1K | Sell |
7,650
-7,000
| -48% | -$915 | ﹤0.01% | 1728 |
|
|
2022
Q3 | $1K | Hold |
14,650
| – | – | ﹤0.01% | 1976 |
|
|
2022
Q2 | $1K | Hold |
14,650
| – | – | ﹤0.01% | 2162 |
|
|
2022
Q1 | $1K | Sell |
14,650
-120
| -0.8% | -$8 | ﹤0.01% | 2344 |
|
|
2021
Q4 | $1K | Hold |
14,770
| – | – | ﹤0.01% | 2336 |
|
|
2021
Q3 | $1K | Buy |
14,770
+120
| +0.8% | +$8 | ﹤0.01% | 2164 |
|
|
2021
Q2 | $1K | Hold |
14,650
| – | – | ﹤0.01% | 1897 |
|
|
2021
Q1 | $1K | Buy |
+14,650
| New | +$1K | ﹤0.01% | 1678 |
|